Free Trial
OTCMKTS:CYDY

CytoDyn (CYDY) Stock Price, News & Analysis

CytoDyn logo
$0.26 0.00 (-0.76%)
As of 01:45 PM Eastern

About CytoDyn Stock (OTCMKTS:CYDY)

Key Stats

Today's Range
$0.26
$0.27
50-Day Range
$0.26
$0.36
52-Week Range
$0.10
$0.49
Volume
769,353 shs
Average Volume
2.78 million shs
Market Capitalization
$326.02 million
P/E Ratio
26.03
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CytoDyn Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

CYDY MarketRank™: 

CytoDyn scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for CytoDyn.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CytoDyn is 25.94, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CytoDyn is 25.94, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.99.

  • Read more about CytoDyn's valuation and earnings.
  • Percentage of Shares Shorted

    3.02% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 3.76%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    CytoDyn does not currently pay a dividend.

  • Dividend Growth

    CytoDyn does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.02% of the outstanding shares of CytoDyn have been sold short.
  • Short Interest Ratio / Days to Cover

    CytoDyn has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in CytoDyn has recently increased by 3.76%, indicating that investor sentiment is decreasing.
  • Search Interest

    1 people have searched for CYDY on MarketBeat in the last 30 days.
  • MarketBeat Follows

    8 people have added CytoDyn to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CytoDyn insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.54% of the stock of CytoDyn is held by insiders.

  • Percentage Held by Institutions

    Only 5.06% of the stock of CytoDyn is held by institutions.

  • Read more about CytoDyn's insider trading history.
Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

CYDY Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
CytoDyn Releases ESMO Breast Cancer Meeting Poster
See More Headlines

CYDY Stock Analysis - Frequently Asked Questions

CytoDyn's stock was trading at $0.1097 at the start of the year. Since then, CYDY stock has increased by 136.2% and is now trading at $0.2591.

CytoDyn Inc. (OTCMKTS:CYDY) posted its earnings results on Friday, July, 25th. The biotechnology company reported ($0.01) earnings per share for the quarter.

Shares of CYDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CytoDyn investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
7/25/2025
Today
8/08/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CYDY
Previous Symbol
NASDAQ:CYDY
CIK
1175680
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.01
Trailing P/E Ratio
25.94
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-4.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.25

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.00 per share
Price / Cash Flow
80.73
Book Value
($0.08) per share
Price / Book
-3.24

Miscellaneous

Outstanding Shares
1,253,930,000
Free Float
1,247,160,000
Market Cap
$324.89 million
Optionable
Not Optionable
Beta
1.23

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:CYDY) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners